| Year |
Citation |
Score |
| 2024 |
Boyle L, Lawrenson R, Ronald M, Campbell I, Nosa V, Tin ST. Ethnic differences in time to surgery for women with early stage breast cancer in Aotearoa/New Zealand: a population-based study. The Lancet Regional Health. Western Pacific. 47: 101091. PMID 38948165 DOI: 10.1016/j.lanwpc.2024.101091 |
0.309 |
|
| 2024 |
Dicks EM, Tyrer JP, Ezquina S, Jones M, Baierl J, Peng PC, Diaz M, Goode E, Winham SJ, Dörk T, Van Gorp T, De Fazio A, Bowtell D, Odunsi K, Moysich K, ... ... Campbell I, et al. Exome sequencing identifies as a novel susceptibility gene for non-mucinous, non-high-grade-serous epithelial ovarian cancer. Medrxiv : the Preprint Server For Health Sciences. PMID 38633804 DOI: 10.1101/2024.04.02.24304968 |
0.382 |
|
| 2024 |
Lawrenson R, Lao C, Stanley J, Teng A, Kuper-Hommel M, Campbell I, Krebs J, Sika-Paotonu D, Koea J, Meredith I, Gurney J. Does diabetes affect breast cancer survival? Cancer Reports (Hoboken, N.J.). 7: e2040. PMID 38507264 DOI: 10.1002/cnr2.2040 |
0.318 |
|
| 2024 |
Barnes DR, Tyrer JP, Dennis J, Leslie G, Bolla MK, Lush M, Aeilts AM, Aittomäki K, Andrieu N, Andrulis IL, Anton-Culver H, Arason A, Arun BK, Balmaña J, Bandera EV, ... ... Campbell I, et al. Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk. Medrxiv : the Preprint Server For Health Sciences. PMID 38496424 DOI: 10.1101/2024.02.29.24303243 |
0.365 |
|
| 2023 |
Stolarova L, Kleiblova P, Zemankova P, Stastna B, Janatova M, Soukupova J, Achatz MI, Ambrosone C, Apostolou P, Arun BK, Auer P, Barnard M, Bertelsen B, Blok MJ, Boddicker N, ... ... Campbell I, et al. ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. OF1-OF14. PMID 37449874 DOI: 10.1158/1078-0432.CCR-23-0212 |
0.386 |
|
| 2022 |
Lao C, Gurney J, Stanley J, Krebs J, Meredith I, Campbell I, Teng A, Sika-Paotonu D, Koea J, Lawrenson R. Association of diabetes and breast cancer characteristics at diagnosis. Cancer Causes & Control : Ccc. PMID 36409455 DOI: 10.1007/s10552-022-01654-y |
0.304 |
|
| 2022 |
DeVries AA, Dennis J, Tyrer JP, Peng PC, Coetzee SG, Reyes AL, Plummer JT, Davis BD, Chen SS, Dezem FS, Aben KKH, Anton-Culver H, Antonenkova NN, Beckmann MW, Beeghly-Fadiel A, ... ... Campbell I, et al. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci. Journal of the National Cancer Institute. PMID 36210504 DOI: 10.1093/jnci/djac160 |
0.315 |
|
| 2022 |
Hakkaart C, Pearson JF, Marquart L, Dennis J, Wiggins GAR, Barnes DR, Robinson BA, Mace PD, Aittomäki K, Andrulis IL, Arun BK, Azzollini J, Balmaña J, Barkardottir RB, Belhadj S, ... ... Campbell I, et al. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers. Communications Biology. 5: 1061. PMID 36203093 DOI: 10.1038/s42003-022-03978-6 |
0.383 |
|
| 2022 |
Lao C, Mondal M, Kuper-Hommel M, Campbell I, Lawrenson R. What affects the public healthcare costs of breast cancer in New Zealand? Asia-Pacific Journal of Clinical Oncology. PMID 36114604 DOI: 10.1111/ajco.13844 |
0.326 |
|
| 2022 |
Scott OW, Tin Tin S, Elwood JM, Cavadino A, Habel LA, Kuper-Hommel M, Campbell I, Lawrenson R. Post-diagnostic beta blocker use and breast cancer-specific mortality: a population-based cohort study. Breast Cancer Research and Treatment. PMID 35286523 DOI: 10.1007/s10549-022-06528-0 |
0.327 |
|
| 2022 |
Lao C, Mondal M, Kuper-Hommel M, Campbell I, Lawrenson R. Differences in Breast Cancer Costs by Cancer Stage and Biomarker Subtype in New Zealand. Pharmacoeconomics - Open. PMID 35184273 DOI: 10.1007/s41669-022-00327-5 |
0.348 |
|
| 2022 |
Dareng EO, Tyrer JP, Barnes DR, Jones MR, Yang X, Aben KKH, Adank MA, Agata S, Andrulis IL, Anton-Culver H, Antonenkova NN, Aravantinos G, Arun BK, Augustinsson A, Balmaña J, ... ... Campbell I, et al. Polygenic risk modeling for prediction of epithelial ovarian cancer risk. European Journal of Human Genetics : Ejhg. PMID 35027648 DOI: 10.1038/s41431-021-00987-7 |
0.312 |
|
| 2021 |
Lao C, Kuper-Hommel M, Campbell I, Elwood M, Lawrenson R. Use and results of systemic treatments for de novo and recurrent metastatic breast cancer: a population-based cohort study. The New Zealand Medical Journal. 134: 47-59. PMID 34788271 |
0.319 |
|
| 2021 |
Barnes DR, Silvestri V, Leslie G, McGuffog L, Dennis J, Yang X, Adlard J, Agnarsson BA, Ahmed M, Aittomäki K, Andrulis IL, Arason A, Arnold N, Auber B, Azzollini J, ... ... Campbell I, et al. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores. Journal of the National Cancer Institute. PMID 34320204 DOI: 10.1093/jnci/djab147 |
0.333 |
|
| 2021 |
Lao C, Elwood M, Kuper-Hommel M, Campbell I, Lawrenson R. Impact of menopausal status on risk of metastatic recurrence of breast cancer. Menopause (New York, N.Y.). PMID 34260475 DOI: 10.1097/GME.0000000000001817 |
0.346 |
|
| 2021 |
Lao C, Kuper-Hommel M, Elwood M, Campbell I, Lawrenson R. Metastatic relapse of stage I-III breast cancer in New Zealand. Cancer Causes & Control : Ccc. PMID 33830387 DOI: 10.1007/s10552-021-01426-0 |
0.316 |
|
| 2021 |
Abrahimi MS, Elwood M, Lawrenson R, Campbell I, Tin Tin S. Associated Factors and Survival Outcomes for Breast Conserving Surgery versus Mastectomy among New Zealand Women with Early-Stage Breast Cancer. International Journal of Environmental Research and Public Health. 18. PMID 33800387 DOI: 10.3390/ijerph18052738 |
0.311 |
|
| 2020 |
Lao C, Kuper-Hommel M, Elwood M, Campbell I, Edwards M, Lawrenson R. Characteristics and survival of de novo and recurrent metastatic breast cancer in New Zealand. Breast Cancer (Tokyo, Japan). PMID 33044617 DOI: 10.1007/s12282-020-01171-3 |
0.323 |
|
| 2020 |
Kang EY, Cheasley D, LePage C, Wakefield MJ, da Cunha Torres M, Rowley S, Salazar C, Xing Z, Allan P, Bowtell DDL, Mes-Masson AM, Provencher DM, Rahimi K, Kelemen LE, Fasching PA, ... ... Campbell I, et al. Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 32724153 DOI: 10.1038/S41379-020-0618-9 |
0.328 |
|
| 2020 |
Barnes DR, Rookus MA, McGuffog L, Leslie G, Mooij TM, Dennis J, Mavaddat N, Adlard J, Ahmed M, Aittomäki K, Andrieu N, Andrulis IL, Arnold N, Arun BK, Azzollini J, ... ... Campbell I, et al. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 32665703 DOI: 10.1038/S41436-020-0862-X |
0.475 |
|
| 2020 |
Silvestri V, Leslie G, Barnes DR, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Barkardottir RB, Barroso A, Barrowdale D, Benitez J, Bonanni B, Borg A, Buys SS, ... ... Campbell I, et al. Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Jama Oncology. PMID 32614418 DOI: 10.1001/Jamaoncol.2020.2134 |
0.474 |
|
| 2020 |
Feng H, Gusev A, Pasaniuc B, Wu L, Long J, Abu-Full Z, Aittomäki K, Andrulis IL, Anton-Culver H, Antoniou AC, Arason A, Arndt V, Aronson KJ, Arun BK, Asseryanis E, ... ... Campbell I, et al. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status. Genetic Epidemiology. PMID 32115800 DOI: 10.1002/gepi.22288 |
0.37 |
|
| 2019 |
Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, ... ... Campbell I, et al. Publisher Correction: Shared heritability and functional enrichment across six solid cancers. Nature Communications. 10: 4386. PMID 31548585 DOI: 10.1038/S41467-019-12095-8 |
0.36 |
|
| 2019 |
Qian F, Rookus MA, Leslie G, Risch HA, Greene MH, Aalfs CM, Adank MA, Adlard J, Agnarsson BA, Ahmed M, Aittomäki K, Andrulis IL, Arnold N, Arun BK, Ausems MGEM, ... ... Campbell I, et al. Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers. British Journal of Cancer. PMID 31213659 DOI: 10.1038/S41416-019-0492-8 |
0.407 |
|
| 2019 |
Grant DJ, Manichaikul A, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy M, Cote ML, Funkhouser E, Moorman PG, Peres LC, Peters ES, Schwartz AG, Terry PD, Wang XQ, Keku TO, ... ... Campbell I, et al. Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women. Cancer Medicine. PMID 31001917 DOI: 10.1002/Cam4.1996 |
0.364 |
|
| 2019 |
Ferreira MA, Gamazon ER, Al-Ejeh F, Aittomäki K, Andrulis IL, Anton-Culver H, Arason A, Arndt V, Aronson KJ, Arun BK, Asseryanis E, Azzollini J, Balmaña J, Barnes DR, Barrowdale D, ... ... Campbell I, et al. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer. Nature Communications. 10: 1741. PMID 30988301 DOI: 10.1038/s41467-018-08053-5 |
0.364 |
|
| 2019 |
Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, ... ... Campbell I, et al. Shared heritability and functional enrichment across six solid cancers. Nature Communications. 10: 431. PMID 30683880 DOI: 10.1038/S41467-018-08054-4 |
0.475 |
|
| 2018 |
Nickson C, Procopio P, Velentzis LS, Carr S, Devereux L, Mann GB, James P, Lee G, Wellard C, Campbell I. Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women. Breast Cancer Research : Bcr. 20: 155. PMID 30572910 DOI: 10.1186/S13058-018-1084-X |
0.42 |
|
| 2018 |
Latt PM, Tin Tin S, Elwood M, Lawrenson R, Campbell I. Receipt of radiotherapy after mastectomy in women with breast cancer: Population-based cohort study in New Zealand. Asia-Pacific Journal of Clinical Oncology. PMID 30430744 DOI: 10.1111/ajco.13101 |
0.31 |
|
| 2018 |
Qian F, Wang S, Mitchell J, McGuffog L, Barrowdale D, Leslie G, Oosterwijk JC, Chung WK, Evans DG, Engel C, Kast K, Aalfs CM, Adank MA, Adlard J, Agnarsson BA, ... ... Campbell I, et al. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. Journal of the National Cancer Institute. PMID 30312457 DOI: 10.1093/jnci/djy132 |
0.33 |
|
| 2018 |
Dixon-Suen SC, Nagle CM, Thrift AP, Pharoah PDP, Ewing A, Pearce CL, Zheng W, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, ... ... Campbell I, et al. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. British Journal of Cancer. PMID 29555990 DOI: 10.1038/S41416-018-0011-3 |
0.439 |
|
| 2018 |
Rebbeck TR, Friebel TM, Friedman E, Hamann U, Huo D, Kwong A, Olah E, Olopade OI, Solano AR, Teo SH, Thomassen M, Weitzel JN, Chan TL, Couch FJ, Goldgar DE, ... ... Campbell I, et al. Mutational Spectrum in a Worldwide Study of 29,700 Families with BRCA1 or BRCA2 Mutations. Human Mutation. PMID 29446198 DOI: 10.1002/Humu.23406 |
0.308 |
|
| 2018 |
Tin Tin S, Elwood JM, Brown C, Sarfati D, Campbell I, Scott N, Ramsaroop R, Seneviratne S, Harvey V, Lawrenson R. Ethnic disparities in breast cancer survival in New Zealand: which factors contribute? Bmc Cancer. 18: 58. PMID 29310606 DOI: 10.1186/s12885-017-3797-0 |
0.303 |
|
| 2018 |
Kader T, Hill P, Opeskin K, Goode D, Elder K, Pang J, Fox S, Mann G, Campbell I, Gorringe K. Abstract PD1-12: Identification of copy number alterations associated with the progression of high risk premalignant breast lesions to breast carcinoma Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Pd1-12 |
0.444 |
|
| 2018 |
Campbell I, Rowley S, Devereux L, McInerny S, Grewal N, Young M, Lee A, Trainer A, James P. Abstract PD1-07: Population genetic testing for breast cancer susceptibility Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Pd1-07 |
0.47 |
|
| 2018 |
Campbell I, Li N, Rowley S, Goode D, Devereux L, McInerny S, Grewal N, Lee A, Trainer A, Wong-Brown M, Scott R, Gorringe K, James P. Abstract PD1-04: The contribution of rare variants, polygenic risk, and novel candidate genes to the hereditary risk of breast cancer in a large cohort of breast cancer families Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Pd1-04 |
0.457 |
|
| 2018 |
Elder K, Kader T, Hill P, Opeskin K, Goode D, Pang J, Fox S, Mann G, Campbell I, Gorringe K. Abstract P3-04-08: Genomic analysis of breast papillomas Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P3-04-08 |
0.333 |
|
| 2018 |
Gorringe K, Hughes S, Nickson C, Devereux L, Pridmore V, Rowley S, Byrne D, Cheasley D, Kavanagh A, Mann G, Fox S, Campbell I. Abstract P3-04-06: Genomic analysis of cancers arising in breasts with different mammographic density Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P3-04-06 |
0.455 |
|
| 2017 |
Milne RL, Kuchenbaecker KB, Michailidou K, Beesley J, Kar S, Lindström S, Hui S, Lemaçon A, Soucy P, Dennis J, Jiang X, Rostamianfar A, Finucane H, Bolla MK, McGuffog L, ... ... Campbell I, et al. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nature Genetics. PMID 29058716 DOI: 10.1038/Ng.3785 |
0.481 |
|
| 2017 |
Lawrenson R, Lao C, Campbell I, Harvey V, Seneviratne S, Edwards M, Elwood M, Scott N, Kidd J, Sarfati D, Kuper-Hommel M. Treatment and survival disparities by ethnicity in New Zealand women with stage I-III breast cancer tumour subtypes. Cancer Causes & Control : Ccc. PMID 29027594 DOI: 10.1007/s10552-017-0969-9 |
0.312 |
|
| 2017 |
Lawrenson R, Lao C, Campbell I, Harvey V, Brown C, Seneviratne S, Edwards M, Elwood M, Kuper-Hommel M. The use of trastuzumab in New Zealand women with breast cancer. Asia-Pacific Journal of Clinical Oncology. PMID 28856817 DOI: 10.1111/ajco.12766 |
0.309 |
|
| 2017 |
Lecarpentier J, Silvestri V, Kuchenbaecker KB, Barrowdale D, Dennis J, McGuffog L, Soucy P, Leslie G, Rizzolo P, Navazio AS, Valentini V, Zelli V, Lee A, Amin Al Olama A, Tyrer JP, ... ... Campbell I, et al. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016694935. PMID 28448241 DOI: 10.1200/Jco.2016.69.4935 |
0.465 |
|
| 2017 |
Seneviratne S, Campbell I, Scott N, Lawrenson R. A cohort study of ethnic differences in use of adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand. Bmc Health Services Research. 17: 64. PMID 28109301 DOI: 10.1186/s12913-017-2027-4 |
0.309 |
|
| 2017 |
Kar SP, Adler E, Tyrer J, Hazelett D, Anton-Culver H, Bandera EV, Beckmann MW, Berchuck A, Bogdanova N, Brinton L, Butzow R, Campbell I, Carty K, Chang-Claude J, Cook LS, et al. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. British Journal of Cancer. PMID 28103614 DOI: 10.1038/Bjc.2016.426 |
0.465 |
|
| 2017 |
Lawrenson R, Lao C, Harvey V, Campbell I, Brown C, Seneviratne S, Edwards M, Scott N, Elwood M, Sarfati D, Kuper-Hommel M. Abstract P4-21-28: Trastuzumab improves outcomes of New Zealand women with HER2+ stage I-III breast cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P4-21-28 |
0.432 |
|
| 2017 |
Campbell I, Trainer A, Devereux L, James P, Rowley S, Li N. Abstract P2-02-01: Identifying the remaining causes of hereditary breast cancer Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P2-02-01 |
0.446 |
|
| 2017 |
Seneviratne S, Scott N, Campbell I, Lawrenson R. Ethnic disparities in breast cancer survival in New Zealand: Why do Māori fare poorly? European Journal of Cancer. 72. DOI: 10.1016/S0959-8049(17)30130-2 |
0.416 |
|
| 2016 |
Permuth JB, Reid B, Earp M, Chen YA, Monteiro AN, Chen Z, Aocs Study Group, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vanderstichele A, Van Niewenhuyse E, Vergote I, Rossing MA, ... ... Campbell I, et al. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. Oncotarget. 7: 72381-72394. PMID 27911851 DOI: 10.18632/Oncotarget.10546 |
0.363 |
|
| 2016 |
Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, Ramus SJ, Li Q, Delgado MK, Lee JM, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, ... ... Campbell I, et al. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nature Communications. 7: 12675. PMID 27601076 DOI: 10.1038/ncomms12675 |
0.358 |
|
| 2016 |
Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dörk T, Claes KB, ... ... Campbell I, et al. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Journal of Medical Genetics. PMID 27595995 DOI: 10.1136/jmedgenet-2016-103839 |
0.361 |
|
| 2016 |
Ong JS, Cuellar-Partida G, Lu Y, Ovarian Cancer Study A, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Anne Doherty J, Anne Rossing M, Chang-Claude J, ... ... Campbell I, et al. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. International Journal of Epidemiology. PMID 27594614 DOI: 10.1093/Ije/Dyw207 |
0.382 |
|
| 2016 |
Vigorito E, Kuchenbaecker KB, Beesley J, Adlard J, Agnarsson BA, Andrulis IL, Arun BK, Barjhoux L, Belotti M, Benitez J, Berger A, Bojesen A, Bonanni B, Brewer C, Caldes T, ... ... Campbell I, et al. Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. Plos One. 11: e0158801. PMID 27463617 DOI: 10.1371/Journal.Pone.0158801 |
0.484 |
|
| 2016 |
Zeng C, Guo X, Long J, Kuchenbaecker KB, Droit A, Michailidou K, Ghoussaini M, Kar S, Freeman A, Hopper JL, Milne RL, Bolla MK, Wang Q, Dennis J, Agata S, ... ... Campbell I, et al. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. Breast Cancer Research : Bcr. 18: 64. PMID 27459855 DOI: 10.1186/S13058-016-0718-0 |
0.458 |
|
| 2016 |
Kar SP, Beesley J, Amin Al Olama A, Michailidou K, Tyrer J, Kote-Jarai Z, Lawrenson K, Lindstrom S, Ramus SJ, Thompson DJ, Kibel AS, Dansonka-Mieszkowska A, Michael A, Dieffenbach AK, ... ... Campbell I, et al. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer Discovery. PMID 27432226 DOI: 10.1158/2159-8290.Cd-15-1227 |
0.505 |
|
| 2016 |
Dixon SC, Nagle CM, Thrift AP, Pharoah PD, Pearce CL, Zheng W, Painter JN, Chenevix-Trench AG, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, Rossing MA, ... ... Campbell I, et al. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. International Journal of Epidemiology. PMID 27401727 DOI: 10.1093/Ije/Dyw158 |
0.443 |
|
| 2016 |
Cuellar-Partida G, Lu Y, Dixon SC, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Doherty JA, Rossing MA, Chang-Claude J, ... ... Campbell I, et al. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. Human Genetics. PMID 27075448 DOI: 10.1007/S00439-016-1663-9 |
0.377 |
|
| 2016 |
Seneviratne S, Lawrenson R, Harvey V, Ramsaroop R, Elwood M, Scott N, Sarfati D, Campbell I. Stage of breast cancer at diagnosis in New Zealand: impacts of socio-demographic factors, breast cancer screening and biology. Bmc Cancer. 16: 129. PMID 26896237 DOI: 10.1186/s12885-016-2177-5 |
0.359 |
|
| 2016 |
Gorringe K, Hunter S, Byrne D, Devereux L, Rowley S, Elder K, Huynh R, Pridmore V, Hopper J, Kavanagh A, Mitchell G, Mann B, Fox S, Campbell I. Abstract P6-02-04: Screen detected and interval cancers; genomic analysis points to different molecular etiology? Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P6-02-04 |
0.443 |
|
| 2016 |
Campbell I, Trainer A, Devereux L, Young M, Mitchell G, Rowley S, Li N, James P, Thompson E. Abstract P2-09-03: Breast cancer prevention: Is it time for population-based mutation screening of high risk genes? Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P2-09-03 |
0.471 |
|
| 2016 |
Campbell I, Thompson E, Rowely S, Li N, McInerny S, Devereux L, Wong-Brown M, Trainer A, Mitchell G, Scott R, James P. Abstract P2-09-02: Panel testing for familial breast cancer: Tension at the boundary of research and clinical care Cancer Research. 76. DOI: 10.1158/1538-7445.Sabcs15-P2-09-02 |
0.482 |
|
| 2015 |
Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, ... ... Campbell I, et al. Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nature Genetics. 48: 101. PMID 26711112 DOI: 10.1038/Ng0116-101B |
0.341 |
|
| 2015 |
Eccles DM, Li N, Handwerker R, Maishman T, Copson ER, Durcan LT, Gerty SM, Jones L, Evans DG, Haywood L, Campbell I. Genetic testing in a cohort of young patients with HER2 amplified breast cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. PMID 26681682 DOI: 10.1093/Annonc/Mdv592 |
0.447 |
|
| 2015 |
Li J, Meeks H, Feng BJ, Healey S, Thorne H, Makunin I, Ellis J, Campbell I, Southey M, Mitchell G, Clouston D, Kirk J, Goldgar D, Chenevix-Trench G. Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families. Journal of Medical Genetics. PMID 26534844 DOI: 10.1136/Jmedgenet-2015-103452 |
0.486 |
|
| 2015 |
Kar SP, Tyrer JP, Li Q, Lawrenson K, Aben KK, Anton-Culver H, Antonenkova N, Chenevix-Trench G, Baker H, Bandera E, Bean YT, Beckmann MW, Berchuck A, Bisogna M, Bjørge L, ... ... Campbell I, et al. Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26209509 DOI: 10.1158/1055-9965.Epi-14-1270 |
0.413 |
|
| 2015 |
Johnatty S, Tyrer JP, Kar SP, Beesley J, Lu Y, Gao B, Fasching PA, Hein A, Ekici AB, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Lambrechts S, Rossing MA, ... ... Campbell I, et al. Genome-wide analysis identifies novel loci associated with ovarian cancer outcomes: findings from the Ovarian Cancer Association Consortium. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26152742 DOI: 10.1158/1078-0432.Ccr-15-0632 |
0.448 |
|
| 2015 |
Peterlongo P, Catucci I, Colombo M, Caleca L, Mucaki E, Bogliolo M, Marin M, Damiola F, Bernard L, Pensotti V, Volorio S, Dall'Olio V, Meindl A, Bartram C, Sutter C, ... ... Campbell I, et al. FANCM c.5791C>T nonsense mutation (rs144567652) induces exon skipping, affects DNA repair activity, and is a familial breast cancer risk factor. Human Molecular Genetics. PMID 26130695 DOI: 10.1093/Hmg/Ddv251 |
0.479 |
|
| 2015 |
Lung MS, Trainer AH, Campbell I, Lipton L. Familial colorectal cancer. Internal Medicine Journal. 45: 482-91. PMID 25955461 DOI: 10.1111/Imj.12736 |
0.331 |
|
| 2015 |
Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Apicella C, Arndt V, ... ... Campbell I, et al. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology. PMID 25940428 DOI: 10.1016/J.Ygyno.2015.04.034 |
0.483 |
|
| 2015 |
Seneviratne S, Lawrenson R, Scott N, Kim B, Shirley R, Campbell I. Breast cancer biology and ethnic disparities in breast cancer mortality in new zealand: a cohort study. Plos One. 10: e0123523. PMID 25849101 DOI: 10.1371/journal.pone.0123523 |
0.318 |
|
| 2015 |
Campbell I, Scott N, Seneviratne S, Kollias J, Walters D, Taylor C, Roder D. Breast cancer characteristics and survival differences between Maori, Pacific and other New Zealand women included in the Quality Audit program of Breast Surgeons of Australia and New Zealand. Asian Pacific Journal of Cancer Prevention : Apjcp. 16: 2465-72. PMID 25824782 |
0.333 |
|
| 2015 |
Seneviratne S, Campbell I, Scott N, Shirley R, Lawrenson R. Impact of mammographic screening on ethnic and socioeconomic inequities in breast cancer stage at diagnosis and survival in New Zealand: a cohort study. Bmc Public Health. 15: 46. PMID 25637343 DOI: 10.1186/s12889-015-1383-4 |
0.307 |
|
| 2015 |
Seneviratne S, Campbell I, Scott N, Coles C, Lawrenson R. Treatment delay for Māori women with breast cancer in New Zealand. Ethnicity & Health. 20: 178-93. PMID 24635721 DOI: 10.1080/13557858.2014.895976 |
0.312 |
|
| 2015 |
Risbridger G, Sliwinski A, Thorne H, Taylor R, Papargiris M, Hunter S, Campbell I, Thorne H, Li J, Mitchell G, Clouston D, Bristow R, Murphy D, Frydenberg M, Bolton D. 2569 Identifying high risk features and genomic instability in men with familial prostate cancer European Journal of Cancer. 51: S500-S501. DOI: 10.1016/S0959-8049(16)31388-0 |
0.341 |
|
| 2014 |
Seneviratne S, Campbell I, Scott N, Kuper-Hommel M, Round G, Lawrenson R. Ethnic differences in timely adjuvant chemotherapy and radiation therapy for breast cancer in New Zealand: a cohort study. Bmc Cancer. 14: 839. PMID 25406582 DOI: 10.1186/1471-2407-14-839 |
0.421 |
|
| 2014 |
Emmanuel C, Chiew YE, George J, Etemadmoghadam D, Anglesio MS, Sharma R, Russell P, Kennedy C, Fereday S, Hung J, Galletta L, Hogg R, Wain GV, Brand A, Balleine R, ... ... Campbell I, et al. Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6618-30. PMID 25316818 DOI: 10.1158/1078-0432.Ccr-14-1292 |
0.329 |
|
| 2014 |
Seneviratne S, Campbell I, Scott N, Shirley R, Peni T, Lawrenson R. Accuracy and completeness of the New Zealand Cancer Registry for staging of invasive breast cancer. Cancer Epidemiology. 38: 638-44. PMID 25037979 DOI: 10.1016/j.canep.2014.06.008 |
0.368 |
|
| 2014 |
Charbonneau B, Moysich KB, Kalli KR, Oberg AL, Vierkant RA, Fogarty ZC, Block MS, Maurer MJ, Goergen KM, Fridley BL, Cunningham JM, Rider DN, Preston C, Hartmann LC, Lawrenson K, ... ... Campbell I, et al. Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome. Cancer Immunology Research. 2: 332-40. PMID 24764580 DOI: 10.1158/2326-6066.Cir-13-0136 |
0.412 |
|
| 2014 |
Block MS, Charbonneau B, Vierkant RA, Fogarty Z, Bamlet WR, Pharoah PD, Rossing MA, Cramer D, Pearce CL, Schildkraut J, Menon U, Kjaer SK, ... ... Campbell I, et al. Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1421-7. PMID 24740199 DOI: 10.1158/1055-9965.Epi-13-0962 |
0.379 |
|
| 2014 |
Charbonneau B, Block MS, Bamlet WR, Vierkant RA, Kalli KR, Fogarty Z, Rider DN, Sellers TA, Tworoger SS, Poole E, Risch HA, Salvesen HB, Kiemeney LA, Baglietto L, Giles GG, ... ... Campbell I, et al. Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Research. 74: 852-61. PMID 24272484 DOI: 10.1158/0008-5472.Can-13-1051 |
0.374 |
|
| 2014 |
James PA, Petelin L, Campbell I, Dawkins H, Fox S, Hiller J, Kirk J, Lindeman G, Macrae F, Mascarenhas L, McGaughran J, Meiser B, Morrow A, Nichols C, Pachter N, et al. The inherited cancer connect (iccon) mutation-carrier database Asia-Pacific Journal of Clinical Oncology. 10: 167-168. DOI: 10.1111/Ajco.12305 |
0.408 |
|
| 2013 |
Southey MC, Park DJ, Nguyen-Dumont T, Campbell I, Thompson E, Trainer AH, Chenevix-Trench G, Simard J, Dumont M, Soucy P, Thomassen M, Jønson L, Pedersen IS, Hansen TV, et al. COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration. Breast Cancer Research : Bcr. 15: 402. PMID 23809231 DOI: 10.1186/Bcr3434 |
0.476 |
|
| 2013 |
Couch FJ, Wang X, McGuffog L, Lee A, Olswold C, Kuchenbaecker KB, Soucy P, Fredericksen Z, Barrowdale D, Dennis J, Gaudet MM, Dicks E, Kosel M, Healey S, Sinilnikova OM, ... ... Campbell I, et al. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. Plos Genetics. 9: e1003212. PMID 23544013 DOI: 10.1371/Journal.Pgen.1003212 |
0.494 |
|
| 2013 |
Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, ... ... Campbell I, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics. 45: 371-84, 384e1-2. PMID 23535731 DOI: 10.1038/Ng.2566 |
0.457 |
|
| 2013 |
Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H, Weber R, Karevan R, Larson MC, Song H, Tessier DC, ... ... Campbell I, et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nature Genetics. 45: 362-70, 370e1-2. PMID 23535730 DOI: 10.1038/Ng.2564 |
0.432 |
|
| 2013 |
Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M, Ziogas A, Zheng W, Yang HP, ... ... Campbell I, et al. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nature Communications. 4: 1628. PMID 23535649 DOI: 10.1038/Ncomms2629 |
0.475 |
|
| 2013 |
Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Chen YA, Tsai YY, Qu X, Ramus SJ, Karevan R, Lee J, Lee N, Larson MC, ... ... Campbell I, et al. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nature Communications. 4: 1627. PMID 23535648 DOI: 10.1038/Ncomms2613 |
0.395 |
|
| 2013 |
White KL, Vierkant RA, Fogarty ZC, Charbonneau B, Block MS, Pharoah PD, Chenevix-Trench G, Rossing MA, Cramer DW, Pearce CL, Schildkraut JM, Menon U, Kjaer SK, Levine DA, ... ... Campbell I, et al. Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 987-92. PMID 23513043 DOI: 10.1158/1055-9965.Epi-13-0028 |
0.456 |
|
| 2013 |
Campbell I, Hunter S, Mathew W, Antill Y, Bae S, Ananda S, Topp M, Lipton L, Liauw W, Jobling T, Boussioutas A, Christie M, Allan P, Friedlander M, Fox S, et al. Abstract A3: Mucinous ovarian tumors: Are they all the same? Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-A3 |
0.412 |
|
| 2013 |
Hunter SM, Gorringe KL, Anglesio MS, Sharma R, Chiew Y, Moss P, Stephens A, Gilks CB, Hunstman D, deFazio A, Campbell I. Abstract A13: Molecular profiling of low grade serous ovarian tumors Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-A13 |
0.323 |
|
| 2013 |
Mitchell G, Campbell I, Dawkins H, Fox S, Hiller J, James P, Kirk J, Lindeman G, Macrae F, McGaughran J, Meiser B, Pachter N, Saunders C, Scott C, Suthers G, et al. An Introduction to ICCon - Inherited Cancer Connect Partnership Asia-Pacific Journal of Clinical Oncology. 9: 113-113. DOI: 10.1111/Ajco.12145 |
0.439 |
|
| 2012 |
Roder D, De Silva P, Zorbas H, Kollias J, Malycha P, Pyke C, Campbell I, Webster F. Survival from synchronous bilateral breast cancer: The experience of surgeons participating in the breast audit of the society of breast surgeons of Australia and New Zealand Asian Pacific Journal of Cancer Prevention. 13: 1413-1418. PMID 22799341 DOI: 10.7314/APJCP.2012.13.4.1413 |
0.33 |
|
| 2012 |
Johnson C, Gorringe K, Thompson E, Opeskin K, Boyle S, Wang Y, Hill P, Mann G, Campbell I. Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma. Hereditary Cancer in Clinical Practice. 10: 1-1. DOI: 10.1186/1897-4287-10-S2-A93 |
0.335 |
|
| 2012 |
Beesley J, Pickett H, Johnatty S, Chen X, Li JJ, Rider D, Stutz M, Lambrecht D, Chang-Claude J, Dork T, Goodman M, Kiemmney B, Bandera E, Kelemen L, Wang-Gorke S, ... Campbell I, et al. Functional polymorphisms in the TERT promoter are associated with risk of serious ovarian and breast cancer Hereditary Cancer in Clinical Practice. 10: 1-2. DOI: 10.1186/1897-4287-10-S2-A86 |
0.482 |
|
| 2012 |
Thompson E, Boyle S, Johnson J, Ryland G, Sawyer S, Choong D, Chenevix-Trench G, Trainer A, Lindeman G, Mitchell G, James P, Campbell I. Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients Hereditary Cancer in Clinical Practice. 10: 1-2. DOI: 10.1186/1897-4287-10-S2-A84 |
0.443 |
|
| 2012 |
Hunter S, Gorringe K, Anglesio M, Sharma R, Gilks B, deFazio A, Huntsman D, Campbell I. Benign serous ovarian tumour: a redefining moment? Hereditary Cancer in Clinical Practice. 10: 1-1. DOI: 10.1186/1897-4287-10-S2-A83 |
0.337 |
|
| 2012 |
Davis S, Simpson K, Campbell I, Gorringe K. Integrated genomic analysis and functional characterisation of novel oncogenes in ovarian cancer Hereditary Cancer in Clinical Practice. 10: 1-1. DOI: 10.1186/1897-4287-10-S2-A81 |
0.401 |
|
| 2012 |
Thompson E, Doyle M, Ellul J, Li J, Campbell I. Identification of breast cancer susceptibility genes using whole exome sequencing Hereditary Cancer in Clinical Practice. 10: 1-1. DOI: 10.1186/1897-4287-10-S2-A41 |
0.464 |
|
| 2011 |
Beesley J, Pickett HA, Johnatty SE, Dunning AM, Chen X, Li J, Michailidou K, Lu Y, Rider DN, Palmieri RT, Stutz MD, Lambrechts D, Despierre E, Lambrechts S, Vergote I, ... ... Campbell I, et al. Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers. Plos One. 6: e24987. PMID 21949822 DOI: 10.1371/Journal.Pone.0024987 |
0.462 |
|
| 2011 |
Amankwah EK, Wang Q, Schildkraut JM, Tsai YY, Ramus SJ, Fridley BL, Beesley J, Johnatty SE, Webb PM, Chenevix-Trench G, Dale LC, Lambrechts D, Amant F, Despierre E, ... ... Campbell I, et al. Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium. Plos One. 6: e19642. PMID 21637745 DOI: 10.1371/Journal.Pone.0019642 |
0.393 |
|
| 2011 |
Pharoah PD, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS, Beckmann MW, Birrer MJ, Bogdanova N, Bolton KL, ... ... Campbell I, et al. The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 3742-50. PMID 21385923 DOI: 10.1158/1078-0432.Ccr-10-3405 |
0.457 |
|
| 2011 |
Campbell I, Qiu W, Haviv I. Genetic changes in tumour microenvironments The Journal of Pathology. 223: 450-458. PMID 21294119 DOI: 10.1002/Path.2842 |
0.374 |
|
| 2010 |
Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, ... ... Campbell I, et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nature Genetics. 42: 880-4. PMID 20852633 DOI: 10.1038/Ng.666 |
0.424 |
|
| 2010 |
Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, Widschwendter M, Vierkant RA, Larson MC, Kjaer SK, Birrer MJ, Berchuck A, Schildkraut J, Tomlinson I, Kiemeney LA, ... ... Campbell I, et al. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nature Genetics. 42: 874-9. PMID 20852632 DOI: 10.1038/Ng.668 |
0.454 |
|
| 2010 |
Handolias DD, Chan P, Phillips W, Fox SB, Pearson R, Sawyer S, Campbell I, Salemi R, McArthur GA. Activation of the PI3K pathway and prognostic information in epithelial ovarian cancer. Journal of Clinical Oncology. 28: 10610-10610. DOI: 10.1200/Jco.2010.28.15_Suppl.10610 |
0.378 |
|
| 2010 |
Thompson E, Ellul J, Li J, Doyle M, Campbell I. Abstract LB-184: Identification of breast cancer susceptibility genes using whole exome sequencing Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-184 |
0.452 |
|
| 2009 |
Campbell I, Polyak K, Haviv I. Clonal Mutations in the Cancer-Associated Fibroblasts: The Case against Genetic Coevolution Cancer Research. 69: 6765-6769. PMID 19706773 DOI: 10.1158/0008-5472.Can-08-4253 |
0.381 |
|
| 2009 |
Haviv I, Polyak K, Qiu W, Hu M, Campbell I. Origin of carcinoma associated fibroblasts. Cell Cycle (Georgetown, Tex.). 8: 589-95. PMID 19182519 DOI: 10.4161/Cc.8.4.7669 |
0.343 |
|
| 2005 |
Kelemen L, James M, Spurdle A, Campbell I, Chang-Claude J, Peel D, Anton-Culver H, Berchuck A, Schildkraut J, Whittemore A, McGurie V, DiCioccio RA, Duffy D, Chenevix-Trench G. BRAF polymorphisms and the risk of ovarian cancer of low malignant potential. Gynecologic Oncology. 97: 807-12. PMID 15904951 DOI: 10.1016/J.Ygyno.2005.03.007 |
0.419 |
|
| 2003 |
Berchuck A, Brewer M, Rodriguez G, Campbell I. Discussion: Ovarian Cancer Prevention Gynecologic Oncology. 88. DOI: 10.1006/Gyno.2002.6687 |
0.423 |
|
| 2002 |
Depasquale S, Lambert-Messerlian G, Quddus MR, Campbell I, Steinhoff M, Gajewski W, Granai C, Tantravahi U. Molecular analysis of inhibin A and activin A subunit gene loci in epithelial ovarian cancer. International Journal of Gynecological Cancer. 12: 443-447. PMID 12366660 DOI: 10.1046/J.1525-1438.2002.01143.X |
0.357 |
|
| 1999 |
Wright K, Wilson P, Morland S, Campbell I, Walsh M, Hurst T, Ward B, Cummings M, Chenevix-Trench G. beta-catenin mutation and expression analysis in ovarian cancer: exon 3 mutations and nuclear translocation in 16% of endometrioid tumours. International Journal of Cancer. 82: 625-9. PMID 10417756 DOI: 10.1002/(Sici)1097-0215(19990827)82:5<625::Aid-Ijc1>3.0.Co;2-2 |
0.331 |
|
| 1998 |
Lanham S, Campbell I, Watt P, Gornall R. p53 polymorphism and risk of cervical cancer The Lancet. 352: 1631. PMID 9843136 DOI: 10.1016/S0140-6736(05)61083-5 |
0.416 |
|
| 1998 |
Campbell I, Thomas E, Hitchcock A, Morland S, Jiang X. Endometriosis and ovarian cancer British Journal of Obstetrics and Gynaecology. 105: 1222-1222. DOI: 10.1111/J.1471-0528.1998.Tb09981_7.X |
0.44 |
|
| Show low-probability matches. |